Results 21 to 30 of about 666,519 (246)

Enhancing the Solubility of Ketoconazole via Pharmaceutical Cocrystal [PDF]

open access: diamondJournal of Physics: Conference Series, 2019
This present research is to synthesized and characterized cocrystal of ketoconazole through cocrystallization process in order to improve solubility properties of ketoconazole.
Indra Indra   +2 more
openalex   +2 more sources

Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid. [PDF]

open access: yesMol Pharm, 2016
Cocrystallization is a technique to optimize solid forms that shows great potential to improve the solubility of active pharmaceutical ingredients (APIs).
Li Z, Matzger AJ.
europepmc   +2 more sources

Control of Pharmaceutical Cocrystal Polymorphism on Various Scales by Mechanochemistry: Transfer from the Laboratory Batch- to the Large-Scale Extrusion Processing

open access: greenACS Sustainable Chemistry and Engineering, 2018
We demonstrate a controllable mechanochemical synthesis of cocrystal polymorphs of ascorbic acid (vitamin C) and nicotinamide (vitamin B3) on different scales and without using bulk solvents.
Tomislav Stolar   +12 more
openalex   +3 more sources

Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications [PDF]

open access: yesPharmaceutics, 2021
Cocrystals have gained attention in the pharmaceutical industry due to their ability to improve solubility, stability, in vitro dissolution rate, and bioavailability of poorly soluble drugs. Conceptually, cocrystals are multicomponent solids that contain
Isabela Fanelli Barreto Biscaia   +3 more
doaj   +3 more sources

Superior solubility and dissolution of zaltoprofen via pharmaceutical cocrystal

open access: diamondTurkish Journal of Pharmaceutical Sciences, 2018
Objective: Pharmaceutical cocrystal is a promising tool to enhance solubility and dissolution of poorly soluble drugs. Zaltoprofen (ZFN) is nonsteroidal antiinflammatory drug with prevalent solubility problem.
Prabhakar Panzade, Giridhar Shendarkar
openalex   +2 more sources

Pharmaceutical cocrystals model drug–receptor interactions [PDF]

open access: bronzeActa Crystallographica Section A Foundations of Crystallography, 2011
M. Tutughamiarso, E. Egert
openalex   +2 more sources

A Randomized, Double-Blind, Two-Treatment, Two-Period, Crossover Study Investigating the Systemic Bioavailability of a Novel Cocrystal Ubiquinol Formulation Compared with a Ubiquinone Formulation in Healthy Adults. [PDF]

open access: yesClin Pharmacol Drug Dev
Abstract Coenzyme Q10 (CoQ10) is a naturally occurring biochemical cofactor found in all human cell membranes in two interconvertible forms: oxidized ubiquinone and reduced ubiquinol. Clinical studies indicate that different CoQ10 formulations have different absorption rates, highlighting research comparing their systemic bioavailability.
Mei X   +4 more
europepmc   +2 more sources

Terahertz and Raman Spectroscopic Investigation of Monohydrate Cocrystal of Antitubercular Isoniazid with Protocatechuic Acid

open access: yesPharmaceutics, 2021
Pharmaceutical cocrystal provides an alternative modification strategy for the formulation development of drugs owning to their potential ability to improve the physicochemical properties of active pharmaceutical ingredients (APIs) efficiently by ...
Yanhua Bo   +6 more
doaj   +1 more source

New Lidocaine-Based Pharmaceutical Cocrystals: Preparation, Characterization, and Influence of the Racemic vs. Enantiopure Coformer on the Physico-Chemical Properties

open access: yesPharmaceutics, 2023
This study describes the preparation, characterization, and influence of the enantiopure vs. racemic coformer on the physico-chemical properties of a pharmaceutical cocrystal.
Panpan Ma   +17 more
doaj   +1 more source

Mechanochemical Synthesis of the Catechol-Theophylline Cocrystal: Spectroscopic Characterization and Molecular Structure

open access: yesApplied Sciences, 2021
Pharmaceutical cocrystallization offers the possibility to modify the physicochemical and biopharmaceutical properties of active pharmaceutical ingredients.
Juan Saulo González-González   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy